CVE-2023-50357 — MEDIUM (5.4)

Q: What is CVE-2023-50357?

CVE-2023-50357 is a vulnerability with a CVSS score of 5.4 (MEDIUM). A cross site scripting vulnerability in the AREAL SAS Websrv1 ASP website allows a remote low-privileged attacker to gain escalated privileges of other non-admin users.

Q: How severe is CVE-2023-50357?

CVE-2023-50357 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2023-50357?

Check the references section above for vendor advisories and patch information. Affected products include: Areal-Topkapi Webserv1.

Vulnerability Description

A cross site scripting vulnerability in the AREAL SAS Websrv1 ASP website allows a remote low-privileged attacker to gain escalated privileges of other non-admin users.

CVSS Score

5.4

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Areal-Topkapi	Webserv1	<= 6.1

Related Weaknesses (CWE)

CWE-79

References

https://www.areal-topkapi.com/en/services/security-bulletinsVendor Advisory
https://www.areal-topkapi.com/en/services/security-bulletinsVendor Advisory

FAQ

What is CVE-2023-50357?

CVE-2023-50357 is a vulnerability with a CVSS score of 5.4 (MEDIUM). A cross site scripting vulnerability in the AREAL SAS Websrv1 ASP website allows a remote low-privileged attacker to gain escalated privileges of other non-admin users.

How severe is CVE-2023-50357?

CVE-2023-50357 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-50357?

Check the references section above for vendor advisories and patch information. Affected products include: Areal-Topkapi Webserv1.